Medicare Enrolled

Dr. Abdul Haseeb, M.D.

Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
7130 N MILLBROOK AVE, Fresno, CA 93720
5593261222
In practice since 2006 (19 years)
NPI: 1407897093 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haseeb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haseeb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haseeb

Dr. Abdul Haseeb is a hematology & oncology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Haseeb performed 488,407 Medicare services across 9,387 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haseeb received a total of $141,904 from 50 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haseeb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in CA $141,904 industry payments

Medicare Practice Summary

Medicare Utilization ↗
488,407
Medicare services
Top 1% in CA for hematology & oncology
9,387
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25,706 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
159,750 $1 $9
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
95,900 $2 $12
Filgrastim-ayow biosimilar injection, 1 microgram
An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram.
40,260 $0 $2
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
30,550 $0 $8
Nivolumab injection (Opdivo) 20,640 $24 $72
Pembrolizumab injection (Keytruda) 15,000 $43 $127
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
14,800 $0 $1
Filgrastim injection (Nivestym) for white blood cells
An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram.
13,380 $0 $9
Denosumab injection (Prolia/Xgeva) 12,000 $19 $51
Eflapegrastim injection, 0.1 mg
An injection of eflapegrastim-xnst administered at a dose of 0.1 mg.
11,748 $26 $88
Anti-nausea injection (aprepitant) 11,570 $1 $11
Injection, granisetron, extended-release, 0.1 mg 8,300 $5 $20
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
7,580 $36 $120
Paclitaxel chemotherapy injection 7,563 $0 $8
Iron infusion (Monoferric) 4,600 $16 $61
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
3,448 $0 $8
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
2,774 $8 $20
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
2,689 $8 $11
Bevacizumab-maly biosimilar injection, 10 mg
An injection of bevacizumab-maly, a biosimilar medication, with a dosage of 10 mg.
2,390 $57 $185
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
2,229 $10 $27
Anti-nausea injection (Aloxi/palonosetron) 1,810 $1 $10
Immune globulin infusion (Octagam)
This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form.
1,750 $33 $225
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,269 $99 $418
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,258 $11 $40
Iron level test 921 $6 $17
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
921 $9 $22
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
894 $13 $35
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
876 $69 $286
Pegfilgrastim-fpgk biosimilar injection, 0.5 mg
An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg.
792 $274 $853
Flow cytometry, additional marker
An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis.
716 $20 $64
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
638 $24 $87
Leuprolide injectable, camcevi, 1 mg 630 $68 $222
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
603 $110 $400
Injection, leucovorin calcium, per 50 mg 575 $3 $13
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 533 $3 $14
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
434 $52 $197
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
396 $2 $10
Carcinoembryonic antigen (CEA) level test
A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer.
339 $18 $48
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
327 $1 $2
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
322 $78 $375
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
310 $2 $12
Immunoglobulin level test
A blood test that measures the level of gammaglobulins, which are immune system proteins.
292 $9 $24
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
252 $1 $9
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
231 $23 $84
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 219 $283 $898
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
213 $1,348 $4,921
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
208 $13 $47
PSA test (prostate cancer screening) 204 $18 $46
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
203 $15 $38
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
201 $54 $194
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
199 $145 $558
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
198 $1 $10
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
172 $17 $61
Electrophoresis laboratory test
A laboratory testing technique that separates molecules based on their size and electrical charge.
161 $60 $154
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
154 $6 $160
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 148 $20 $53
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
146 $62 $222
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
139 $3 $9
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
119 $129 $450
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
98 $50 $145
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
85 $4 $11
Beta-2 microglobulin level test
A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body.
84 $16 $41
Injection, alteplase recombinant, 1 mg 80 $67 $220
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
79 $96 $252
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
78 $1 $9
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
67 $25 $90
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
60 $261 $943
CA 19-9 tumor antigen test
A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen.
57 $20 $53
New patient office visit, complex (60-74 min) 54 $176 $594
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
51 $47 $171
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
45 $16 $42
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
45 $72 $306
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
40 $121 $628
CT scan of abdomen with and without contrast
A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures.
40 $199 $709
Central venous tube declotting
A procedure to clear a blockage or clot from a central venous catheter to restore its function.
38 $27 $94
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
38 $51 $149
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
37 $4 $14
Prolonged intravenous chemotherapy administration
This procedure involves the administration of chemotherapy medication directly into a vein over an extended period.
36 $110 $410
Injection, hydrocortisone sodium succinate, up to 100 mg 33 $13 $36
Flow cytometry DNA or cell analysis, first marker
A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell.
31 $62 $193
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
29 $140 $521
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
29 $3,632 $9,900
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
24 $6 $16
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $51 $248
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
21 $1,353 $4,921
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
21 $7 $17
Free T3 thyroid hormone test
A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning.
19 $17 $43
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
17 $148 $479
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
17 $9 $23
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
16 $29 $74
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
16 $4 $10
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
16 $72 $153
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
16 $32 $307
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
12 $14 $37
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
12 $20 $62
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.0% high complexity
60.4% medium
3.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$141,904
Total received (2018-2024)
Avg $20,272/year across 7 years
Top 6% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$134,620 (94.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,658 (3.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,626 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25,130
2023
$44,970
2022
$22,620
2021
$23,592
2020
$10,317
2019
$10,124
2018
$5,151

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$12,901
SOBI, INC
$10,934
Celgene Corporation
$232
Daiichi Sankyo Inc.
$161
AstraZeneca Pharmaceuticals LP
$106
GlaxoSmithKline, LLC.
$105
Novartis Pharmaceuticals Corporation
$101
SEAGEN INC.
$100
Exelixis Inc.
$98
ABBVIE INC.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$50
EMD Serono, Inc.
$42
Ipsen Biopharmaceuticals, Inc
$38
Regeneron Healthcare Solutions, Inc.
$36
ARRAY BIOPHARMA INC
$27
SpringWorks Therapeutics, Inc.
$26
BeiGene USA, Inc.
$20
Sirtex Medical Inc
$20
Kite Pharma, Inc.
$18
Merck Sharp & Dohme LLC
$16
PFIZER INC.
$13
Top 3 companies account for 95.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$73,796
Exelixis Inc.
$37,182
SOBI, INC
$20,331
Celgene Corporation
$2,530
Sobi, Inc
$1,540
Rigel Pharmaceuticals, Inc.
$1,170
Seattle Genetics, Inc.
$931
GlaxoSmithKline, LLC.
$466
Amgen Inc.
$410
AstraZeneca Pharmaceuticals LP
$403
Athenex Pharmaceutical Division, LLC
$350
Novartis Pharmaceuticals Corporation
$313
Pharmacyclics LLC, An AbbVie Company
$247
Daiichi Sankyo Inc.
$217
Kite Pharma, Inc.
$204
Genentech USA, Inc.
$141
GENZYME CORPORATION
$124
ABBVIE INC.
$108
Gilead Sciences, Inc.
$108
SEAGEN INC.
$100
AVEO Pharmaceuticals, Inc.
$100
Astellas Pharma US Inc
$99
Ipsen Biopharmaceuticals, Inc
$79
EMD Serono, Inc.
$78
Janssen Biotech, Inc.
$78
Cook Medical LLC
$77
Pharmacyclics LLC, an AbbVie Company
$70
Takeda Pharmaceuticals U.S.A., Inc.
$66
Incyte Corporation
$57
BeiGene USA, Inc.
$49
Lilly USA, LLC
$45
TerSera Therapeutics LLC
$42
Merck Sharp & Dohme Corporation
$41
Regeneron Healthcare Solutions, Inc.
$36
Cardinal Health 108, LLC
$27
ARRAY BIOPHARMA INC
$27
SpringWorks Therapeutics, Inc.
$26
Coherus Biosciences Inc.
$25
Myovant Sciences Inc.
$24
JAZZ PHARMACEUTICALS INC.
$23
MorphoSys, US Inc.
$20
Sirtex Medical Inc
$20
Seagen Inc.
$18
Eisai Inc.
$18
Merck Sharp & Dohme LLC
$16
PUMA BIOTECHNOLOGY, INC.
$15
Deciphera Pharmaceuticals Inc.
$14
PharmaEssentia USA Corporation
$14
PFIZER INC.
$13
Ferring Pharmaceuticals Inc.
$13
Top 3 companies account for 92.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · ALIMTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COOK MEDICAL HEMOSPRAY · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · EMPLICITI · ENHERTU · EPKINLY · Enhertu · FARXIGA · FIRMAGON · FOTIVDA · FRUZAQLA · Fabhalta · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NERLYNX · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PLUVICTO · POLIVY · Perjeta · Pomalyst · QINLOCK · REBLOZYL · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · Tavalisse · Tazverik · Trodelvy · Udenyca · VENCLEXTA · VOTRIENT · VYXEOS · Vanflyta · XGEVA · YERVOY · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology & oncology in CA.

Looking for a hematology & oncology specialist in Fresno?
Compare hematology & oncology specialists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Haseeb is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Haseeb experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Haseeb performed 159,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haseeb receive payments from pharmaceutical companies?
Yes. Dr. Haseeb received a total of $141,904 from 50 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haseeb's costs compare to other hematology & oncology specialists in Fresno?
Dr. Haseeb's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haseeb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →